French Health Authority Approves Qalsody Reimbursement
The Haute Autorité de Santé (HAS) has issued a favorable opinion for the reimbursement of the drug Qalsody. This decision provides a new treatment option for patients suffering from Amyotrophic Lateral Sclerosis (ALS).
Topics
Developing
- 863d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 863d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 863d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 863d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
Bluesky
“Après des mois d'incertitude pour les patients atteints de Sclérose latérale amyotrophique (SLA), la HAS donne enfin un avis favorable au remboursement du Qalsody.”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade